UDP-glucuronosyltransferases in conjugation of 5α- and 5β-androstane steroids

Drug Metabolism and Disposition

Volumn 37, Issue 11, 2009, Pages 2221-2227

  Sten, Taina ^a   Kurkela, Mika ^a   Kuuranne, Tiia ^b   Leinonen, Antti ^b   Finel, Moshe ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Yhtyneet Laboratoriot Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA ANDROSTANE 3ALPHA ,17BETA DIOL (5ALPHA DIOL); 5BETA ANDROSTANE 3ALPHA ,17BETA DIOL (5ALPHA DIOL); ANDROSTANE DERIVATIVE; ANDROSTERONE; ETIOCHOLANOLONE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 2A1; GLUCURONOSYLTRANSFERASE 2A2; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B17; GLUCURONOSYLTRANSFERASE 2B7; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CATALYSIS; CONJUGATION; ENZYME SPECIFICITY; GENETIC POLYMORPHISM; GLUCURONIDATION; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANDROSTANES; ANDROSTERONE; CELL LINE; GLUCURONOSYLTRANSFERASE; HUMANS; ISOENZYMES; RECOMBINANT PROTEINS;

EID: 70350277708     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.029231     Document Type: Article

References (23)

1. Bélanger A, Brochu M, Lacoste D, Noël C, Labrie F, Dupont A, Cusan L, Caron S, and Couture J (1991) Steroid glucuronides: human circulatory levels and formation by LNCaP cells. J Steroid Biochem Mol Biol 40:593-598.
2. Bélanger A, Pelletier G, Labrie F, Barbier O, and Chouinard S (2003) Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479. (Pubitemid 37517349)
3. Chouinard S, Pelletier G, Bélanger A, and Barbier O (2006) Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology 147:5431-5442. (Pubitemid 44790598)
4. Coffman BL, King CD, Rios GR, and Tephly TR (1998) The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26:73-77. (Pubitemid 28071328)
5. Green MD, Oturu EM, and Tephly TR (1994) Stable expression of a human liver UDPglucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22:799-805.
6. Green MD and Tephly TR (1996) Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 24:356-363.
7. Itaaho K, Mackenzie PI, Ikushiro S, Miners JO, and Finel M (2008) The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 36:2307-2315.
8. Jakobsson J, Ekström L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlström K, and Rane A (2006) Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693. (Pubitemid 43236944)
9. Jedlitschky G, Cassidy AJ, Sales M, Pratt N, and Burchell B (1999) Cloning and characterization of a novel human olfactory UDP- glucuronosyltransferase. Biochem J 340:837-843. (Pubitemid 29312884)
10. Jin CJ, Mackenzie PI, and Miners JO (1997) The regio- and stereo-selectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11. Arch Biochem Biophys 341:207-211.
11. King CD, Rios GR, Green MD, and Tephly TR (2000) UDP- glucuronosyltransferases. Curr Drug Metab 1:143-161.
12. Kurkela M, Patana AS, Mackenzie PI, Court MH, Tate CG, Hirvonen J, Goldman A, and Finel M (2007) Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genomics 17:115-126. (Pubitemid 46263426)
13. Kuuranne T, Kurkela M, Thevis M, Schänzer W, Finel M, and Kostiainen R (2003) Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31:1117-1124. (Pubitemid 37048283)
14. Lépine J, Bernard O, Plante M, Têtu B, Pelletier G, Labrie F, Bélanger A, and Guillemette C (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232. (Pubitemid 39391472)
15. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685. (Pubitemid 41345319)
16. Mareck U, Geyer H, Opfermann G, Thevis M, and Schänzer W (2008) Factors influencing the steroid profile in doping control analysis. J Mass Spectrom 43:877-891. (Pubitemid 352029656)
17. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
18. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
19. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, and Rane A (2008) Doping test results dependent on genotype of uridine diphospho- glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93:2500-2506. (Pubitemid 352008513)
20. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, et al. (2000) Bioanalytical method validation - a revisit with a decade of progress. Pharm Res 17:1551-1557. (Pubitemid 32217566)
21. Sten T, Bichlmaier I, Kuuranne T, Leinonen A, Yli-Kauhaluoma J, and Finel M (2009) UDP-glucuronosyltransferases (UGTs)2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 37:417-423.
22. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
23. Turgeon D, Carrier JS, Lévesque E, Hum DW, and Bélanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787. (Pubitemid 32222427)